Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

ChromoGenics announces a conditional loan of 47,6 MSEK is converted to a grant

ChromoGenics announces a conditional loan of 47,6 MSEK is converted to a grant The Swedish Energy Agency changes its decision from November 29, 2012, so that support in the form of an advance with repayment obligation to ChromoGenics AB (Conditional Loan) is now converted to a grant. On November 29, 2012, ChromoGenics AB was granted support to carry out a project by the Energy Agency. The support was provided in the form of an advance with a repayment obligation (Conditional Loan), which is a loan where the repayment conditions depend on the project's outcome. The Swedish Energy

BioStock: BioInvent to present promising clinical data at ASCO and EHA

In the coming weeks, BioInvent is set to present three significant data sets at the American Society for Clinical Oncology’s (ASCO) annual congress and the European Hematology Association’s (EHA) annual meeting. At ASCO, BioInvent will showcase advancements with BI-1808 monotherapy and BI-1206 in combination with Keytruda. At EHA, promising data on BI-2106 will be presented to the expert community.Read the article at biostock.se: https://www.biostock.se/en/2024/05/bioinvent-to-present-promising-clinical-data-at-asco-and-eha/ This is a press release from BioStock - Connecting

Lundbergs Interim Report January - March 2024

· On March 31, 2024, net asset value after deferred tax amounted to SEK 142.8 billion (SEK 576 per share), compared with SEK 135.1 billion (SEK 545 per share) on December 31, 2023. The corresponding values on May 28, 2024 were SEK 141.2 billion (SEK 569 per share).  · Consolidated net sales amounted to SEK 7,982 m. (8,062).  · Profit after financial items amounted to SEK 4,863 m. (3,883) where earnings from participations in associated companies amounted toSEK 3,352 m. (2,646). Profit after financial items excluding unrealized changes in value amounted to SEK 5,706 m. (5,385).

5,000 patients treated with OssDsign Catalyst® in the U.S.

Uppsala, May 30, 2024. Today, OssDsign AB (publ.) announces that the company continues its successful penetration of the U.S. orthobiologics market. To date, 5,000 patients have been treated with the innovative nanosynthetic bone graft OssDsign Catalyst.The continuous and rapid increase in treated patients is a strong testament to how well OssDsign Catalyst has been received in the U.S. market since its launch in August 2021.   “With 5,000 patients treated, the use of OssDsign Catalyst is not just growing, it's accelerating. This is a significant leap from the earlier announcements of

Issue, repurchase and reclassification of shares of series C and transfer of ordinary shares under LTIP 2024

In light of the incentive program adopted by the annual general meeting of Medivir AB (publ) (“Medivir”) on 7 May 2024 (“LTIP 2024”), it is today announced that the board of directors of Medivir has resolved on (i) a share issue of 1,700,000 shares of series C, (ii) repurchase of the 1,700,000 shares of series C, (iii) reclassification of 114,587 shares of series C into ordinary shares and (iv) partial execution of the annual general meeting’s resolution on transfer of own ordinary shares by transferring 126,000 own ordinary shares to participants in LTIP 2024.Aktieinvest FK AB will

poLight ASA - Invitation to presentation of Q1 2024 results

poLight ASA (OSE: PLT) will release its first quarter 2024 results on Tuesday 4 June 2024 at 7.00 am CEST. The quarterly report and presentation will be made available on the company's website www.polight.com and www.newsweb.no. CEO Øyvind Isaksen and CFO Alf Henning Bekkevik will present the company's results at 09:00 am CEST at Continental, Stortingsgaten 24/26, in Oslo, Norway which is open to the public. The presentation and supporting material will be in English. The presentation can also be followed through live webcast. Please join the Q1 2024 results webcast by https://channel.

Grocery retailer Alphamega orders 37 MSEK of electronic shelf labels

Pricer’s partner StrongPoint has signed an agreement with Alphamega, the largest grocery retailer in Cyprus, to install electronic shelf labels in all its stores. The value of the contract is approximately 37 MSEK and the rollout is expected to begin in 2024 and be completed by 2026.“We are excited that our solution will support Alphamega in its digitalization journey. The adoption of our cloud-based platform Pricer Plaza represents a significant leap forward and empowers this leading retailer with centralized control and management of pricing, product information, and promotions across all

DanCann Pharma A/S: Minutes OF ANNUAL GENERAL MEETING

held in DanCann Pharma A/S, CVR-no. 39 42 60 05 (“Company”)Thursday, 30 May 2024 at 09:00 am (CET) On 30 May 2024 at 09:00 am (CET), the annual general meeting of 2024 was held in the Company at the Company’s address, Rugvænget 5, 6823 Ansager, Denmark. The agenda for the annual general meeting was as follows: 6. `. 1. 1. 1. 1. 1. The chairman’s report on the activities of the Company in the past financial year 2. Adoption of the annual report for 2023 3. Covering of loss pursuant to the adopted

Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology

Södertälje, Sweden, & San Francisco, USA and Kyoto, Japan, 30 May 2024 – Anocca AB  (Anocca), a leading T-cell receptor-engineered T-cell (TCR-T) therapeutics company, and Shinobi Therapeutics (Shinobi), developer of immune-evasive induced pluripotent stem cell (iPSC)-derived CD8 αβT-cell therapies (iPS-T), today announced a strategic partnership to use Shinobi’s proprietary immune evasive iPS-T cell platform with novel candidate TCRs, discovered and validated by Anocca, to develop a new class of off-the-shelf allogeneic TCR engineered iPS-T-cell therapies (TCR-iPS-T)

Collegiate style for the wrist

Preppy in primary colors: NOMOS Tangente 38 date Love in red, white, and blue.GLASHÜTTE, MAY 24, 2024. Whether worn with cashmere, check, or a pleated skirt and tennis socks—this watch combines modern design with classic style and always remains straightforward, flattering, and perfectly proportioned. An elegant answer to the question of whether there is a watch that goes with everything, and a wonderful way to elevate more casual, everyday outfits. Key Facts Tangente 38 date Love Colors:red, white, blue(brick red, cream, pool blue, orange) Target group:sporty, neat,

Dive into the blue with Super Sardine

With this watch on your wrist, you will always make a splash—even on dry land. A must-have for all those who want to add a maritime flair to their look.GLASHÜTTE, MAY 30, 2024. Inspired by the many shades of the sea, Tangente Super Sardine brings a nautical touch to everyday life. This NOMOS watch with a date display represents perseverance, character, confidence, and common sense. Whether worn while on vacation by the coast or while planning the next trip at home, with smart casual or more formal attire—Tangente Super Sardine guarantees elegance and buoyancy in any situation. Key Facts

ODI Pharma AB: Publication of interim report Q3 2023/2024

ODI Pharma AB (“ODI” or the “Company”) hereby publishes its interim report for the period July 2023 - March 2024. The report is available as an attached document to this press release and on the Company’s website (www.odipharma.com). Below is a summary of the report.Third quarter (2024-01-01 – 2024-03-31)The Group's net sales amounted to SEK 13,856,539 (10,801).The Group's profit after financial items amounted to SEK 1,389,713 (-942,440).Result per share amounted to SEK 0,09 (-0.06).*  Nine months (2023-07-01 – 2024-03-31)The Group’s net sales amounted to SEK 14,777,194 (112,

Railway Metrics and Dynamics Sweden AB (publ) has received approval for delisting from Spotlight Stock Market and approval for listing on NGM Nordic SME

Railway Metrics and Dynamics Sweden AB ("RMD") announces that Spotlight has approved the company's application for delisting from Spotlight Stock Market. The last trading day on Spotlight Stock Market is scheduled for May 30, 2024. RMD has received approval for listing on Nordic SME on Nordic Growth Market ("NGM") with the first trading day on May 31, 2024.The list change marks a significant milestone in RMD's strategic transition to NGM Nordic SME. The list change is expected to support RMD's efforts to improve operational efficiency and expand the company's presence in European markets.

Hines appoints Trevian to develop lease operations in Helsinki CBD - Kasarmikatu 21 addresses the city’s most vital demand for office space

Hines has appointed Trevian Asset Management Oy to develop the lease operations of the Kasarmikatu 21 office building located in Helsinki. Currently, the largest corporate accounts of this LEED Platinum-certified property are Roschier and Danske Bank. The first new office building of the millennium in Helsinki's central business district has particularly attracted the finance and asset management industry as well as law firms.Hines is one of the world's largest privately owned investment, development, and property management firms, with USD 93.2 billion in assets under management. The

Hoist Finance acquires a portfolio of SEK 10 bn and deepens partnership with Lowell

As announced in Lowell Group’s earnings report for the first quarter 2024 published today, Hoist Finance has acquired a portfolio from Lowell Germany. The portfolio has an outstanding balance of SEK 10 billion and will be serviced by Lowell Germany under a six-year servicing agreement, in an arrangement similar to our collaboration in The UK and in Sweden. “This transaction is another example of our strong partnership with the Lowell Group and our continued focus on collaborating with industry peers across Europe. We at Hoist Finance remain committed to acting as a value adding problem

Annual General Meeting in Nordhealth AS

The Annual General Meeting (the "AGM") of Nordhealth AS (the "Company") was held on 30 May 2024 at 10:00 hours (CET). The minutes of the AGM are attached, as well as the attendance list and voting protocol. All resolutions were approved in accordance with the proposal from the board of directors including, inter alia, a board authorization to increase the share capital with up to NOK 12,028,761.90 by issuance of new shares and to acquire treasury shares for an amount of up to NOK 12,028,761.90. These authorizations will replace the previous authorizations issued at the annual general

Voi offers free rides for national Car Free challenge

[Scooter and bike] Above: People riding an e-bike and e-scooter. Credit: Voi Micromobility rental company, Voi, is offering free e-bike and e-scooter rides to support a national Car Free Challenge taking place during June. Climate action charity, Possible, is challenging people across the UK to cut their car use from 1-30 June, either by swapping the daily commute from the car to another form of transport, swapping the car for a bike, or pledging to go car free for a day, week or the whole month. New Voi riders can enjoy a free 30 minutes ride on an e-scooter or e-bike to help

Ponsse Plc - Managers' Transactions, Juho Nummela

Ponsse Plc, Managers’ Transactions, 30 May, 2024 at 11:30 a.m (EEST) Ponsse Plc - Managers' Transactions, Juho Nummela Ponsse Plc has received the following disclosure on May 30, 2024: Person subject to the notification requirementName: Nummela, JuhoPosition: Chief Executive Officer Issuer: Ponsse PlcLEI: 7437000IQJS6ZC1FR041 Notification type: INITIAL NOTIFICATIONReference number: 7437000IQJS6ZC1FR041_20240530100506_29 Transaction date: 2024-05-29Venue not applicableInstrument type: SHAREISIN: FI0009005078Nature of the transaction: RECEIPT OF A SHARE-BASED

Press invitation to the 7th IFPA Conference

IFPA, the International Federation of Psoriasis Associations, invites you to cover the 7th IFPA Conference at Stockholm Waterfront Congress Centre, June 27-29, 2024. The theme of the conference is “Uncovering the broad spectrum of psoriatic disease”.This summer, world-leading experts within dermatology and rheumatology will be gathering in Stockholm to share significant achievements in the prevention, diagnosis, and treatment of psoriatic disease. Together with attendees they will also discuss where to focus future efforts across the spectrum of basic, translational, and clinical research

Ependion acquires a minority stake in Blu Wireless

Ependion's business entity Westermo has today signed an agreement to acquire a minority stake in UK headquartered Blu Wireless Technology Ltd. The investment amounts to 3.4 million pounds. At the same time, Westermo has entered into a strategic partnership agreement to use Blu Wireless’ patented mmWave wireless technology in the rail market.“Westermo is the global market leader in communication on board trains. With this strategic investment and partnership, we are strengthening our position in the connected trains market by gaining access to ground-breaking new technology for train-to-

Camurus’ Board of Directors exercises authorization for repurchase of shares for the purpose of securing the company’s commitments under the Performance Share Plan 2024/2027

Lund, Sweden — 30 May 2024 — The Annual General Meeting of Camurus on 8 May 2024, resolved – for the purpose of ensuring that the company can fulfill its commitments under the long-term incentive program for employees of the Camurus group resolved by the Annual General Meeting (Performance Share Plan 2024/2027) – on a directed share issue of no more than 240,000 redeemable and convertible series C shares. Carnegie Investment Bank AB (publ) has subscribed for all 240,000 series C shares. The subscription price amounted to SEK 0.025 per share, which corresponds to the quota value of the

ITAB makes strategic investment in Signatrix' Retail AI technology

ITAB Group has made a strategic investment in Signatrix GmbH, a technology and Retail AI startup. ITAB and Signatrix started collaborating in 2022 and have together created frictionless security deterrents that reduce product loss for the retail sector, specifically in the checkout area in stores. This partnership is now strengthened and together with Signatrix, ITAB intends to develop solutions and support scaling the business opportunities in the grocery, DIY, and other retail sectors. ITAB sees Retail AI as an integral part of its own technology platform.ITAB is one of the market leaders

There are no items matching the current filter
There are no more items matching the current filter
Back to top